As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...

The primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with tanruprubart at a dose of 30 mg/kg recovered to a healthy state with a score of 0 or ...

Scientists have linked Zika firmly to Guillain-Barré syndrome, known for triggering temporary paralysis.

Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground.

This announcement was made alongside the reveal of positive Phase 3 results for Tanruprubart, a monoclonal antibody that can block C1q and can potentially halt neuroinflammation and nerve damage in ...

Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...

Megyn Kelly, the American journalist, regrets her decision to get the Covid-19 vaccine, citing an autoimmune diagnosis ...

Guillain-Barré Syndrome: The Frightening Illness Linked to Your Favourite Foods.(Photo by RDNE Stock) She pointed out, “A plant-based diet of whole foods naturally enhances immunity by ...

We present a case of Guillain-Barré syndrome in a child who received hepatitis A vaccine 5 days before onset of the clinical symptoms. In our patient, the association of Guillain-Barré syndrome ...

To beef up its case for tanruprubart, Annexon also announced on Wednesday that a real-world study of the drug likewise showed a “rapid increase in muscle strength” versus current standards of care in ...